3400 3295.9 IMPORTANCE OF 3200 PHARMACEUTICAL R&D 3000 2800 In 2023 the pharmaceutical industry invested about € 52,400 million in R&D in Europe. A decade of strong 2600 US market dominance led to a significant shift of economic and research activity...
More
3400 3295.9 IMPORTANCE OF 3200 PHARMACEUTICAL R&D 3000 2800 In 2023 the pharmaceutical industry invested about € 52,400 million in R&D in Europe. A decade of strong 2600 US market dominance led to a significant shift of economic and research activity towards the US during 2400 the periods 1995-2005 and 2015-2020, a trend that has been somewhat slowing down following the 2200 COVID pandemic. Additionally, Europe is now facing increasing competition from emerging economies: rapid growth in the market and research environments 2000 in countries such as China are contributing to the move of economic and research activities to non-European 1600 markets. In 2024 China outpaced both US and Europe as originators of new active substances launched for 1400 1368.0 the first time on the world market. In 2024, out of a total of 81 new molecules, 28 originated from Chinese 1200 (including Hong Kong) headquartered companies whilst 25 and 18 originated from US and European 1000 headquartered companies
Less
